Other Assets

3 Months Ended

Mar. 31, 2025

Other Assets [Abstract]

Other Assets

Other Assets

The following table presents the components of other assets as of the dates indicated:

(In millions)	March 31, 2025		December 31, 2024
Securities borrowed(1)	$	41,602	$	37,451
Derivative instruments, net	7,260		11,183
Bank-owned life insurance	3,880		3,856
Collateral, net	3,584		3,216
Investments in joint ventures and other unconsolidated entities(2)	3,424		3,317
Accounts receivable	975		504
Prepaid expenses	873		738
Right-of-use assets	826		818
Deferred tax assets, net of valuation allowance(3)	646		701
Receivable for securities settlement	328		57
Income taxes receivable	308		144
Other(4)	2,820		2,529
Total	$	66,526	$	64,514

(1) Refer to Note 8, for further information on the impact of collateral on our financial statement presentation of securities borrowing and securities lending transactions.

(2) Includes equity securities without readily determinable fair values that are accounted for under the ASC 321 measurement alternative of $414 million and $341 million as of March 31, 2025 and December 31, 2024, respectively. For the three months ended March 31, 2025, no impairments were recognized in other fee revenue related to such equity securities.

(3) Deferred tax assets and liabilities recorded in our consolidated statement of condition are netted within the same tax jurisdiction.

(4) Includes advances of $1.30 billion and $1.04 billion as of March 31, 2025 and December 31, 2024, respectively.